Back to the Top
The following message was posted to: PharmPK
Dear all,
I am looking for reviews about link between biomonitoring and PBTK.
Could someone be kind enough to help me?
Best regards
Jerome HENRI
Back to the Top
The following message was posted to: PharmPK
Jerome, here are some papers describing the use of PBTK for reverse dosimetry. I hope this helps.
Lyons MA, Yang RS, Mayeno AN, and Reisfeld B. (2008). Computational Toxicology of Chloroform: Reverse Dosimetry Using Bayesian Inference, Markov Chain Monte Carlo Simulation, and Human Biomonitoring Data. Environ Health Perspect 116(8): 1040-1046.
Liao, KH, Tan, YM, and Clewell, HJ. (2007). Development of a screening approach to interpret human biomonitoring data on volatile organic compounds (VOCs): Reverse dosimetry on biomonitoring data for trichloroethylene. Risk Analysis 27: 12231236.
Tan, YM, Liao, KH, and Clewell, HJ. (2007). Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling. Journal of Exposure Science and Environmental Epidemiology 71(7): 591603.
Clewell, HJ, Tan, YM, Campbell, JM, and Andersen, ME. (2008). Quantitative interpretation of human biomonitoring data. Toxicology and Applied Pharmacology 231L: 122-133.
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Biomonitoring" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)